Boston Scientific (BSX) FCF Margin (2009 - 2026)

Boston Scientific has disclosed FCF Margin across 18 years of filings, most recently posting 3.29% for Q1 2026.

• FCF Margin for Q1 2026 came in at 3.29%, down 431.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 16.86% (down 31.0% YoY), and the FY2025 annual result was 18.22%, up 243.0% from the prior year.
• FCF Margin came in at 3.29% for Q1 2026 at Boston Scientific, down from 19.16% in the prior quarter.
• In the past five years, FCF Margin ranged from a high of 25.85% in Q4 2024 to a low of 5.92% in Q1 2022.
• The 5-year median for FCF Margin is 14.4% (2023), against an average of 12.62%.
• Peak annual rise in FCF Margin reached 1157 bps in 2022, while the deepest fall reached 1351 bps in 2022.
• Boston Scientific's FCF Margin stood at 18.35% in 2022, then grew by 1 bps to 18.52% in 2023, then jumped by 40 bps to 25.85% in 2024, then dropped by 26 bps to 19.16% in 2025, then plunged by 83 bps to 3.29% in 2026.
• The last three FCF Margin figures came in at 3.29% (Q1 2026), 19.16% (Q4 2025), and 22.94% (Q3 2025), per Business Quant data.